Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles T Quinn

Showing results (1-10 of 147) with videos related to

Pageof 15
Sort By:
Experimental Biology and Medicine (Maywood, N.J.)|March 26, 2016
Minireview: Clinical severity in sickle cell disease: the challenges of definition and prognosticationCharles T Quinn
Pediatric Blood & Cancer|July 15, 2015
Do not leave for tomorrow what you can do todayCharles T Quinn
Seminars in Hematology|May 11, 2026
More disease-modifying therapies for sickle cell disease: Are small molecules and drug repurposing the way forward?Charles T Quinn
Pediatric Clinics of North America|November 19, 2013
Sickle cell disease in childhood: from newborn screening through transition to adult medical careCharles T Quinn
Blood|June 14, 2018
l-Glutamine for sickle cell anemia: more questions than answersCharles T Quinn
Pediatric Blood & Cancer|December 19, 2008
A question of quality in sickle cell diseaseCharles T Quinn
Hematology. American Society of Hematology. Education Program|February 20, 2015
Breakthrough: new guidance for silent cerebral ischemia and infarction in sickle cell diseaseCharles T Quinn
Blood|February 23, 2023
Hydroxyurea: how much is enough?Charles T Quinn
Blood|October 20, 2018
Silent cerebral infarction: supply and demandCharles T Quinn
Experimental Biology and Medicine (Maywood, N.J.)|January 28, 2020
L-glutamine for sickle cell disease: Knight or pawn?Alina Sadaf, Charles T Quinn
Pageof 15

Showing results (1-10 of 147) with videos related to

Sort By:
Pageof 15
Experimental Biology and Medicine (Maywood, N.J.)|March 26, 2016
Minireview: Clinical severity in sickle cell disease: the challenges of definition and prognosticationCharles T Quinn
Pediatric Blood & Cancer|July 15, 2015
Do not leave for tomorrow what you can do todayCharles T Quinn
Seminars in Hematology|May 11, 2026
More disease-modifying therapies for sickle cell disease: Are small molecules and drug repurposing the way forward?Charles T Quinn
Pediatric Clinics of North America|November 19, 2013
Sickle cell disease in childhood: from newborn screening through transition to adult medical careCharles T Quinn
Blood|June 14, 2018
l-Glutamine for sickle cell anemia: more questions than answersCharles T Quinn
Pediatric Blood & Cancer|December 19, 2008
A question of quality in sickle cell diseaseCharles T Quinn
Hematology. American Society of Hematology. Education Program|February 20, 2015
Breakthrough: new guidance for silent cerebral ischemia and infarction in sickle cell diseaseCharles T Quinn
Blood|February 23, 2023
Hydroxyurea: how much is enough?Charles T Quinn
Blood|October 20, 2018
Silent cerebral infarction: supply and demandCharles T Quinn
Experimental Biology and Medicine (Maywood, N.J.)|January 28, 2020
L-glutamine for sickle cell disease: Knight or pawn?Alina Sadaf, Charles T Quinn
Pageof 15